SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-148145
Filing Date
2024-05-28
Accepted
2024-05-28 16:51:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d704939ds3.htm S-3 160394
2 EX-5.1 d704939dex51.htm EX-5.1 7964
3 EX-23.1 d704939dex231.htm EX-23.1 1854
4 EX-FILING FEES d704939dexfilingfees.htm EX-FILING FEES 19863
5 GRAPHIC g704939g0524074547824.jpg GRAPHIC 2652
6 GRAPHIC g704939g23l04.jpg GRAPHIC 14412
7 GRAPHIC g704939g65b34.jpg GRAPHIC 15032
  Complete submission text file 0001193125-24-148145.txt   235940
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279760 | Film No.: 24992718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)